HROB Induces Lung Adenocarcinoma Progression via ZC3HC1 ‐ CCNB1 Axis Regulation and Cell Cycle Dysregulation
Cancer Science · 2025
DOI: 10.1111/cas.70141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Zhe Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Cyclin B1, Lung Neoplasms, Adaptor Proteins, Signal Transducing. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Research and Development Program of Hunan Province of China, National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD), a leading cause of cancer‐related mortality, remains a significant global health challenge due to limited understanding of its molecular mechanisms. HROB, a recently identified gene, has been implicated in cell cycle regulation, but its role in lung cancer progression is poorly understood. In this study, we demonstrate that HROB suppresses LUAD progression by interacting with ZC3HC1 and reducing its phosphorylation at Ser354. This de‐phosphorylation event facilitates K27‐linked ubiquitination of CCNB1, promoting its proteasomal degradation and impairing the G2‐to‐M phase transition. Consequently, HROB suppresses cell proliferation and tumor growth. Our findings reveal a novel HROB–ZC3HC1–CCNB1 regulatory axis, providing mechanistic insights into LUAD progression. These results highlight HROB as a potential therapeutic target, offering new avenues for clinical intervention in lung cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Health Management Center, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Emergency Medicine, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Emergency Medicine, Guilin Hospital of the Second Xiangya Hospital of Central South University, Guilin, China.
ORCID-Profile: Bin Wang
Förderung
- Key Research and Development Program of Hunan Province of China
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Zhang, Z., Wang, C., Guo, Y., Zhao, Z., Yang, Z., Xie, S., Hu, X., Huang, X., Jiang, Y., Xiao, B., Wang, L., Yu, F., & Wang, B. (2025). HROB Induces Lung Adenocarcinoma Progression via ZC3HC1 ‐ CCNB1 Axis Regulation and Cell Cycle Dysregulation. Cancer Science. https://doi.org/10.1111/cas.70141
Vancouver
Zhang Z, Wang C, Guo Y, Zhao Z, Yang Z, Xie S, et al. HROB Induces Lung Adenocarcinoma Progression via ZC3HC1 ‐ CCNB1 Axis Regulation and Cell Cycle Dysregulation. Cancer Science. 2025. doi:10.1111/cas.70141
BibTeX
@article{Zhang2025,
author = {Zhang, Zhe and Wang, Cheng and Guo, Yuanwei and Zhao, Zhenyu and Yang, Zhi and Xie, Shouzhi and Hu, Xinhang and Huang, Xingchun and Jiang, Yupeng and Xiao, Bing and Wang, Li and Yu, Fenglei and Wang, Bin},
title = {HROB Induces Lung Adenocarcinoma Progression via ZC3HC1 ‐ CCNB1 Axis Regulation and Cell Cycle Dysregulation},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70141}
}
EUVIMED